Intellectual Property India Publishes Patent Application for 'An Antigen-Binding Fragment Or Antibody Against Snake Venom Metalloproteinases, Corresponding Methods, Composition, And Kit Thereof' Filed by Indian Institute Of Science; Liverpool School Of Tropical Medicine; and International AIDS Vaccine Initiative

MUMBAI, India, April 17 -- Intellectual Property India has published a patent application (202541032415 A) filed by Indian Institute Of Science; Liverpool School Of Tropical Medicine; and International AIDS Vaccine Initiative, Bengaluru, Karnataka, on April 1, 2025, for 'an antigen-binding fragment or antibody against snake venom metalloproteinases, corresponding methods, composition, and kit thereof.'

Inventor(s) include R R Senji Laxme; Kartik Sunagar; Joseph Jardine; Nicholas Casewell; and Elise Landais.

The application for the patent was published on April 17, under issue no. 16/2026.

According to the abstract released by the Intellectual Property India: "The present disclosure relates to broadly neutralising antigen binding fragments or antibody against snake venom metalloproteinases (SVMPs) and neutralises the lethal effects of snake venom. The present disclosure also provides corresponding methods of preparation, compositions, vectors, hosts, method of treatment/diagnosis, use and kits thereof."

Disclaimer: Curated by HT Syndication.